2021 Korean Heart Rhythm Society Guidelines for Catheter or Surgical Ablation of Atrial Fibrillation

Chungang uihak = The Korean central journal of medicine Pub Date : 2022-02-01 DOI:10.3904/kjm.2022.97.1.5

W. Lim, J. Shim, Ji Hyun Lee, B. Joung

{"title":"2021 Korean Heart Rhythm Society Guidelines for Catheter or Surgical Ablation of Atrial Fibrillation","authors":"W. Lim, J. Shim, Ji Hyun Lee, B. Joung","doi":"10.3904/kjm.2022.97.1.5","DOIUrl":null,"url":null,"abstract":"Rhythm control therapy is used in atrial fibrillation (AF) management to improve AF-related symptoms along with rate control. AF catheter ablation is effective in maintaining sinus rhythm and has an acceptable complication rate. Compared with antiarrhythmic drugs, AF catheter ablation is superior with respect to arrhythmia-free survival and improvement in the quality of life. Therefore, AF ablation is recommended for rhythm control after the failure of antiarrhythmic drugs and is sometimes considered a first-line therapy for AF patients. Radiofrequency and cryoballoon ablation show similar efficacy, with slightly different complication profiles. Surgery for AF is also an effective rhythm control therapy and should be considered in patients undergoing cardiac surgery or in those with failed catheter ablation. For patients undergoing AF catheter ablation, performing ablation under uninterrupted warfarin or non-vitamin K oral anticoagulant treatment is recommended for periprocedural stroke risk management. Here, we review existing data and discuss the general principles of AF catheter and surgical ablation in patients with AF.","PeriodicalId":84452,"journal":{"name":"Chungang uihak = The Korean central journal of medicine","volume":"31 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chungang uihak = The Korean central journal of medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3904/kjm.2022.97.1.5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Rhythm control therapy is used in atrial fibrillation (AF) management to improve AF-related symptoms along with rate control. AF catheter ablation is effective in maintaining sinus rhythm and has an acceptable complication rate. Compared with antiarrhythmic drugs, AF catheter ablation is superior with respect to arrhythmia-free survival and improvement in the quality of life. Therefore, AF ablation is recommended for rhythm control after the failure of antiarrhythmic drugs and is sometimes considered a first-line therapy for AF patients. Radiofrequency and cryoballoon ablation show similar efficacy, with slightly different complication profiles. Surgery for AF is also an effective rhythm control therapy and should be considered in patients undergoing cardiac surgery or in those with failed catheter ablation. For patients undergoing AF catheter ablation, performing ablation under uninterrupted warfarin or non-vitamin K oral anticoagulant treatment is recommended for periprocedural stroke risk management. Here, we review existing data and discuss the general principles of AF catheter and surgical ablation in patients with AF.

查看原文本刊更多论文

2021韩国心律学会心房颤动导管或手术消融指南

心律控制治疗用于房颤(AF)治疗，以改善房颤相关症状和控制房颤的发生率。房颤导管消融对维持窦性心律有效，并发症发生率可接受。与抗心律失常药物相比，房颤导管消融在无心律失常生存和改善生活质量方面具有优势。因此，房颤消融被推荐用于抗心律失常药物失效后的心律控制，有时被认为是房颤患者的一线治疗方法。射频消融和低温球囊消融的疗效相似，但并发症略有不同。手术治疗房颤也是一种有效的心律控制治疗方法，在接受心脏手术或导管消融失败的患者中应予以考虑。对于接受房颤导管消融的患者，建议在不间断华法林或非维生素K口服抗凝治疗下进行消融，以进行围手术期卒中风险管理。在这里，我们回顾了现有的数据，并讨论了房颤患者房颤导管和手术消融的一般原则。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Chungang uihak = The Korean central journal of medicine

自引率

0.00%

发文量